The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Andrew Frankart receives $729,000 ACS/ASTRO Clinician Scientist Development Grant

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Andrew Frankart received a five-year, $729,000 American Cancer Society/American Society for Radiation Oncology Clinician Scientist Development Grant to lead a clinical trial at the University of Cincinnati Cancer Center that will test the safety and effectiveness of a more targeted radiation dose for patients with large tumors.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Sponsored

The War on Cancer: After half a century of progress, a promising prognosis may be Richard Nixon’s greatest legacy

Fifty-four years ago, in his State of the Union Message in January 1971, President Nixon proposed a visionary and vigorous new challenge.  He said “The time has come in America when the same kind of concentrated effort that split the atom and took man to the moon” should be applied to finding a cure for cancer.  He followed up by requesting an appropriation of $100 million, and the promise to ask for whatever additional funds could be effectively used.  
By Jim Byron
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account